Macrogenics reported $72.38M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 8821M 991M
Amgen AMGN:US $ 3.74B 804M
AstraZeneca AZN:LN 10.51B 1.79B
Cerulean Pharma CERU:US $ 9.54M 3.13M
Daiichi Sankyo 4568:JP 284.67B 42.7B
Genmab GEN:DC 1.61B 205M
Geron GERN:US $ 28.8M 3.22M
Immunogen IMGN:US $ 60.93M 1.62M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Xencor XNCR:US $ 59.03M 3.33M